国际眼科纵览 ›› 2012, Vol. 36 ›› Issue (3): 177-182.doi: 10 3760/ cma. j. issn. 16735803 2012 03 007

• 综述 • 上一篇    下一篇

干细胞疗法及其在脉络膜新生血管治疗中的应用前景

侯慧媛  梁宏亮  王雨生   

  1. 710032 西安,第四军医大学西京医院眼科 全军眼科研究所(侯慧媛、王雨生);第四军医大学西京医院心血管外科 全军心血管病研究所(梁宏亮)
  • 收稿日期:2012-03-16 出版日期:2012-06-22 发布日期:2012-06-29
  • 通讯作者: 王雨生,Email:wangys003@126com E-mail:wangys003@126.com

Stem cell therapy and its application to the treatment for choroidal neovascularization

HOU Hui-yuan, LIANG Hong-liang, WANG Yu-sheng   

  1. Department of Ophthalmology, Eye Institute of Chinese PLA; Department of Cardiovascular Surgery, Institute of Cardiovascular Disease of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China
  • Received:2012-03-16 Online:2012-06-22 Published:2012-06-29
  • Contact: WANG Yu-sheng, Email: wangys003@126.com E-mail:wangys003@126.com

摘要: 脉络膜新生血管形成(choroidal neovascularization, CNV)常造成严重视力损害,对其治疗方法的探索是相关医学工作者研究和关注的热点。研究发现干细胞参与CNV生成,为干细胞疗法治疗CNV带来契机。本文就干细胞疗法治疗CNV的原理、研究基础、治疗策略、初步探索、优势和前景等作一综述。

Abstract: Choroidal neovascularization (CNV) is a common cause of severe and irreversible visual loss. Therefore, the exploration of the treatment for CNV is always the focus of relative medical researches. Investigations indicated that stem cells contribute to CNV formation, which brings opportunity for the application of stem cell therapy to CNV treatment. In this review, we discuss the principle, foundation, strategy, preliminary research, advantages and outlook of stem cells application.